Precision Biosciences Stock Alpha and Beta Analysis
| DTIL Stock | USD 9.74 0.98 9.14% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Precision BioSciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Precision BioSciences over a specified time horizon. Remember, high Precision BioSciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Precision BioSciences' market risk premium analysis include:
Beta 0.34 | Alpha 0.0302 | Risk 6.9 | Sharpe Ratio 0.0048 | Expected Return 0.0333 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Precision |
Precision BioSciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Precision BioSciences market risk premium is the additional return an investor will receive from holding Precision BioSciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Precision BioSciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Precision BioSciences' performance over market.| α | 0.03 | β | 0.34 |
Precision BioSciences expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Precision BioSciences' Buy-and-hold return. Our buy-and-hold chart shows how Precision BioSciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Precision BioSciences Market Price Analysis
Market price analysis indicators help investors to evaluate how Precision BioSciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Precision BioSciences shares will generate the highest return on investment. By understating and applying Precision BioSciences stock market price indicators, traders can identify Precision BioSciences position entry and exit signals to maximize returns.
Precision BioSciences Return and Market Media
The median price of Precision BioSciences for the period between Sat, Jan 20, 2024 and Fri, Apr 19, 2024 is 12.01 with a coefficient of variation of 13.14. The daily time series for the period is distributed with a sample standard deviation of 1.65, arithmetic mean of 12.59, and mean deviation of 1.22. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Precision BioSciences Receives Pre-IND Feedback from US FDA for PBGENE-HBV as it Advances Towards Clinical Readiness | 02/14/2024 |
2 | iECURE Secures Approval from U.K. Medicines Healthcare Products Regulatory Agency to Expand the OTC-HOPE Study of ECUR-506 | 03/06/2024 |
3 | Liquidia Technologies, Inc. Reports Q4 Loss, Lags Revenue Estimates | 03/13/2024 |
4 | Precision BioSciences to Release Earnings on Wednesday - MarketBeat | 03/21/2024 |
5 | Acquisition by John Kelly of 20000 shares of Precision BioSciences at 0.86 subject to Rule 16b-3 | 03/22/2024 |
6 | 03/26/2024 |
7 | Precision BioSciences GAAP EPS of -4.06 misses by 2.03, revenue of 7.04M misses by 7.42M | 03/27/2024 |
8 | Precision Biosciences, Mesoblast, Pulse Biosciences among healthcare movers - Seeking Alpha | 04/01/2024 |
9 | iECURE Announces FDA Clearance of Investigational New Drug Application for ECUR-506 to Initiate OTC-HOPE Trial for Treatment of Neonatal Onset Ornithine Transca... | 04/04/2024 |
10 | Precision BioSciences Now Trades Above Golden Cross Time to Buy | 04/11/2024 |
About Precision BioSciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Precision or other stocks. Alpha measures the amount that position in Precision BioSciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2023 | 2024 (projected) | Payables Turnover | 7.35 | 2.78 | 2.64 | Days Of Inventory On Hand | 306.14 | 275.53 | 244.91 |
Precision BioSciences Upcoming Company Events
As portrayed in its financial statements, the presentation of Precision BioSciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Precision BioSciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Precision BioSciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Precision BioSciences. Please utilize our Beneish M Score to check the likelihood of Precision BioSciences' management manipulating its earnings.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Precision BioSciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Precision BioSciences Backtesting, Precision BioSciences Valuation, Precision BioSciences Correlation, Precision BioSciences Hype Analysis, Precision BioSciences Volatility, Precision BioSciences History and analyze Precision BioSciences Performance. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Precision Stock analysis
When running Precision BioSciences' price analysis, check to measure Precision BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Precision BioSciences is operating at the current time. Most of Precision BioSciences' value examination focuses on studying past and present price action to predict the probability of Precision BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Precision BioSciences' price. Additionally, you may evaluate how the addition of Precision BioSciences to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Precision BioSciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.